本文選題：苯扎氯銨 + 結(jié)膜下組織纖維化��； 參考：《廈門大學(xué)》2014年碩士論文

【摘要】：目的：苯扎氯銨(benzalkonium chloride, BAC)是滴眼液中最常用的防腐劑。大量臨床及實(shí)驗(yàn)研究表明,長(zhǎng)期使用含BAC的滴眼液會(huì)引起一系列的眼表不良反應(yīng)。本研究主要探討B(tài)AC致結(jié)膜下組織纖維化的機(jī)制。 方法：SD雄性大鼠45只,隨機(jī)分成對(duì)照組、實(shí)驗(yàn)組和細(xì)胞培養(yǎng)組,每組15只。對(duì)照組和實(shí)驗(yàn)組分別用PBS和0.01%BAC滴左眼,每天兩次,每12小時(shí)一次。一個(gè)月后,取大鼠左眼球結(jié)膜組織提取蛋白和RNA及制備石蠟包埋切片；細(xì)胞培養(yǎng)組取大鼠左眼球結(jié)膜成纖維細(xì)胞(CFs)進(jìn)行原代培養(yǎng),分別用PBS、0.00005%BAC、0.000075%BAC、0.000075%BAC+LY2157299(TGF-PR1抑制劑,200μM、0.000075%BAC+NS-398(COX-2抑制劑,100μ M)作用于細(xì)胞,24小時(shí)后提取蛋白和RNA。以Western Blot (WB)和qRT-PCR方法檢測(cè)結(jié)膜組織和原代培養(yǎng)的CFs的細(xì)胞外基質(zhì)(I型膠原a1鏈,CollAl;纖維連接蛋白-1,FN-1),TGF-βp信號(hào)通路相關(guān)分子(TGF-β1TGF-βR1TGF-βR2 Smad2、 Smad3. P-Smad3)和COX-2的蛋白及mRNA表達(dá)水平,并以蘇木素-伊紅染色法(HE)、苦味酸-酸性品紅染色法(Van Gieson's),過碘酸-希夫染色法(PAS)和免疫組織化學(xué)染色法觀察結(jié)膜下組織的病理改變及炎癥細(xì)胞的浸潤(rùn)情況。 結(jié)果：HE、Van Gieson's及PAS染色結(jié)果顯示,0.01%BAC處理組球結(jié)膜上皮細(xì)胞及杯狀細(xì)胞的形態(tài)和數(shù)量與PBS對(duì)照組相比無明顯不同,但結(jié)膜下組織成纖維細(xì)胞密度輕微增加,有明顯的膠原纖維沉積；免疫組織化學(xué)染色顯示,0.01%BAC處理組球結(jié)膜下組織未見中性粒細(xì)胞和巨噬細(xì)胞浸潤(rùn)；WB和qRT-PCR結(jié)果顯示,BAC處理組球結(jié)膜組織和原代培養(yǎng)的CFs CollAl FN-1COX-2, TGF-β1 TGF-βRK Smad3, P-Smad3蛋白或mRNA的表達(dá)均顯著高于PBS對(duì)照組,而TGF-βpR2和Smad2蛋白的表達(dá)與PBS對(duì)照組相比無明顯差異；0.000075%BAC+LY2157299細(xì)胞處理組,P-Smad3、CollAl和FN-1的蛋白表達(dá)均顯著低于0.000075%BAC處理組；0.000075%BAC+NS-398細(xì)胞處理組,TGF-β1 TGF-βR1、Smad3、P-Smad3蛋白表達(dá)均顯著低于0.000075%BAC處理組。 結(jié)論：BAC通過COX-2激活TGF-β1/Smad3信號(hào)通路,引起結(jié)膜下成纖維細(xì)胞產(chǎn)生大量細(xì)胞外基質(zhì)從而引起結(jié)膜下組織纖維化。
[Abstract]:Objective: benzalkonium chloride (BAC) is the most commonly used antiseptic in eye drops. A large number of clinical and experimental studies have shown that long-term use of BAC-containing eye drops can cause a series of adverse eye surface reactions. The purpose of this study was to investigate the mechanism of subconjunctival fibrosis induced by BAC. Methods 45 male Sprague-Dawley rats were randomly divided into control group, experimental group and cell culture group with 15 rats in each group. The control group and the experimental group were treated with PBS and 0.01 C drops of left eye twice a day every 12 hours. One month later, protein and RNA were extracted from the conjunctiva of the left eye and paraffin embedded sections were prepared, and CFS of the left conjunctiva fibroblasts of the left eye were taken from the cell culture group for primary culture. PBS, 0.00005C, 0.000075C, 0.000075C, 0.000075C LY2157299TGF-PR1 inhibitor 200 渭 M, 0.000075C NS-398COX-2 inhibitor 100 渭 M) were used to extract protein and RNA for 24 hours. Western blot and qRT-PCR were used to detect the extracellular matrix type I collagen A1 chain collagen A 1 chain of conjunctival tissue and primary cultured CFS. TGF- 尾 1 TGF- 尾 R 1 TGF- 尾 R 2 Smad2, Smad3, TGF- 尾 1 TGF- 尾 R 1 TGF- 尾 R 2, Smad3, TGF- 尾 1 TGF- 尾 R 1 TGF- 尾 R 2, Smad3 were detected by Western blot and qRT-PCR. The protein and mRNA expression levels of P-Smad3) and COX-2, The pathological changes of subconjunctival tissue and the infiltration of inflammatory cells were observed by hematoxylin-eosin staining, picric acid-acid fuchsin staining and periodate-Schiff staining. Results the morphology and number of bulbar conjunctival epithelial cells and goblet cells in 0.01C treated group were not significantly different from those in PBS control group, but the density of fibroblasts in subconjunctival tissue increased slightly. Immunohistochemical staining showed that there was no infiltration of neutrophils and macrophages in subconjunctival tissue of 0.01C group. The results of WB and qRT-PCR showed that the expressions of protein and mRNA in conjunctiva and CFS CollAl FN-1COX-2, TGF- 尾 1TGF- 尾 RK Smad3 and P-Smad3 in BAC treated group were significantly higher than those in PBS control group, but the expression of TGF- 尾 pR2 and Smad2 protein in BAC group was not significantly different from that in PBS control group. The protein expression of P-Smad3A1CollAl and FN-1 in 0.000075C LY2157299 cell group was significantly lower than that in 0.000075C treated group, and the expression of TGF- 尾 1 TGF- 尾 1 TGF- 尾 1 TGF- 尾 Smad3 + P-Smad3 protein in 0.000075C treated group was significantly lower than that in 0.000075C group. ConclusionBAC activates TGF- 尾 1 / Smad3 signaling pathway through COX-2, which results in a large amount of extracellular matrix produced by subconjunctival fibroblasts and subconjunctival fibrosis.
【學(xué)位授予單位】：廈門大學(xué)
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2014
【分類號(hào)】：R965

【參考文獻(xiàn)】

相關(guān)期刊論文 前10條

1 盧謙益;陶黎明;;青光眼濾過性手術(shù)的最新進(jìn)展[J];安徽醫(yī)藥;2009年07期

2 謝琳,賀翔鴿;TGF-β抑制劑(Decorin)抗濾過泡瘢痕形成及毒副作用的實(shí)驗(yàn)研究[J];第三軍醫(yī)大學(xué)學(xué)報(bào);2001年09期

3 王炯;TGF－β的生物學(xué)效應(yīng)及其在某些疾病中的作用[J];國(guó)外醫(yī)學(xué).免疫學(xué)分冊(cè);1995年01期

4 鄭素軍;邢欣悅;韓源平;武聚山;王世美;張瑩;劉梅;陳煜;劉霜;段鐘平;;TGF-β1對(duì)大鼠HSC-T6細(xì)胞增殖、細(xì)胞周期和膠原分泌的影響[J];實(shí)用肝臟病雜志;2012年04期

5 高燕;袁魯亮;譚虎;;環(huán)氧化酶-2在實(shí)驗(yàn)性腎間質(zhì)纖維化大鼠腎組織中的表達(dá)及意義[J];華北國(guó)防醫(yī)藥;2009年04期

6 史辛藝;梁碩;王志斌;關(guān)方霞;;TGF-β/Smads信號(hào)通路在疾病發(fā)生中的作用[J];河南醫(yī)學(xué)研究;2012年02期

7 王啟偉,樸英杰;Smad蛋白與TGF-β超家族[J];解剖科學(xué)進(jìn)展;2003年04期

8 李偉忠;丁彥青;李祖國(guó);張進(jìn)華;;舌癌組織中COX-2的表達(dá)及與腫瘤血管生成的關(guān)系[J];口腔醫(yī)學(xué)研究;2008年03期

9 楊芳;藍(lán)彩娟;陳希哲;;轉(zhuǎn)化生長(zhǎng)因子β1與創(chuàng)傷愈合及瘢痕形成[J];昆明醫(yī)學(xué)院學(xué)報(bào);2009年S2期

10 張蕾;孫開宇;;大鼠肺纖維化過程中轉(zhuǎn)化生長(zhǎng)因子-β_1在不同肺組織中的表達(dá)變化及意義[J];臨床合理用藥雜志;2011年09期

，

本文編號(hào)：2016220